Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Sof Rbv'

Sof Rbv published presentations and documents on DocSlides.

SOF + EBR + GZR + RBV

SOF + EBR + GZR + RBV

  • test
  • 4 Slides

N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...

SOF + RBV

SOF + RBV

  • debby-jeon
  • 7 Slides

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

SOF/VEL

SOF/VEL

  • trish-goza
  • 6 Slides

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

SOF/VEL + RBV

SOF/VEL + RBV

  • celsa-spraggs
  • 5 Slides

N = 69. >. 18 years. Failure to SOF/VEL . or ...

SOF/VEL 400/100 mg qd N = 75

SOF/VEL 400/100 mg qd N = 75

  • danika-pritchard
  • 0 Slides

W24. SOF/VEL. >. 18 years. Chronic HCV infect...

SIRIUS

SIRIUS

  • tawny-fly
  • 10 Slides

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

  • cheryl-pisano
  • 36 Slides

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

COSMOS

COSMOS

  • sherrill-nordquist
  • 8 Slides

SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...

FISSION Design Objective

FISSION Design Objective

  • travis
  • 6 Slides

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

SOF/VEL

SOF/VEL

  • lois-ondreau
  • 9 Slides

400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...

SOF/VEL/VOX

SOF/VEL/VOX

  • celsa-spraggs
  • 9 Slides

400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...

C-SWIFT Study: elbasvir/grazoprevir + SOF

C-SWIFT Study: elbasvir/grazoprevir + SOF

  • pamella-moone
  • 10 Slides

in genotypes 1 or 3, with or without cirrhosis. &...

LDV/SOF

LDV/SOF

  • conchita-marotz
  • 5 Slides

Open-label. Chronic HCV infection. Genotype 1 . F...

C-SWIFT Study: elbasvir/grazoprevir + SOF

C-SWIFT Study: elbasvir/grazoprevir + SOF

  • myesha-ticknor
  • 11 Slides

in genotypes 1 or 3, with or without cirrhosis. &...

SOF/VEL/VOX

SOF/VEL/VOX

  • pamella-moone
  • 7 Slides

400/100/100 mg QD. N = 263. N = 152. W12. Placebo...

SMV 150 mg QD SOF 400 mg QD

SMV 150 mg QD SOF 400 mg QD

  • alida-meadow
  • 0 Slides

Randomisation. 1 : 1. 18-70 years. HCV genotype 1...

SMV + DCV + SOF Open label

SMV + DCV + SOF Open label

  • summer
  • 6 Slides

≥ 18 years. Chronic HCV infection. Genotype 1 or...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

  • mitsue-stanley
  • 15 Slides

With Or Without Ribavirin Is Safe and Efficacious...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

  • mitsue-stanley
  • 15 Slides

With Or Without Ribavirin Is Safe and Efficacious...

Sofosbuvir, Ribavirin, GS

Sofosbuvir, Ribavirin, GS

  • min-jolicoeur
  • 7 Slides

-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

  • kittie-lecroy
  • 0 Slides

Interim Analysis of a French Multicenter Compassi...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

  • sophia
  • 54 Slides

April 10. –14. , 2019. Vienna, Austria. Disclaim...

Safety and Efficacy of Daclatasvir

Safety and Efficacy of Daclatasvir

  • tabitha
  • 14 Slides

. Plus . Sofosbuvir. With or Without Ribavirin . ...

Out With the Old and In With the New, Again?

Out With the Old and In With the New, Again?

  • test
  • 37 Slides

Out With the Old, In With the New. Current Standa...

HIV and HCV Update for the Pharmacist – June 2014

HIV and HCV Update for the Pharmacist – June 2014

  • marina-yarberry
  • 60 Slides

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...

Updated Guidelines for Managing HIV/HCV Co-Infection

Updated Guidelines for Managing HIV/HCV Co-Infection

  • karlyn-bohler
  • 0 Slides

John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

  • giovanna-bartolotta
  • 0 Slides

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • danika-pritchard
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • trish-goza
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

MK3 MK3 + RBV

MK3 MK3 + RBV

  • min-jolicoeur
  • 10 Slides

Randomisation. Open-label. W8. * Liver biopsy or ...

PEG alfa-2a RBV versus

PEG alfa-2a RBV versus

  • alexa-scheidler
  • 0 Slides

. PEG alfa-. 2a . versus. INF RBV . APRICOT S...

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

  • sophia2
  • 9 Slides

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

  • UnicornLove
  • 7 Slides

C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...

Mr. John A. Wilcox

Mr. John A. Wilcox

  • sherrill-nordquist
  • 26 Slides

Director, J6/CIO . United States Special Operatio...

1 SOCOM

1 SOCOM

  • pamella-moone
  • 14 Slides

Acquisition Perspective . to. . NDIA. James W. C...

SMV 150 mg

SMV 150 mg

  • faustina-dinatale
  • 5 Slides

qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....

ION-4

ION-4

  • briana-ranney
  • 8 Slides

Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...

LDV/SOF 90/400 mg

LDV/SOF 90/400 mg

  • aaron
  • 4 Slides

qd. Non-randomised. Open-label. N =. 21. W12. SV...

ALLY-2

ALLY-2

  • tawny-fly
  • 8 Slides

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

ALLY-2

ALLY-2

  • aaron
  • 8 Slides

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

Copyright © 2024 DocSlides. All Rights Reserved